Acute kidney injury following endovascular intervention for peripheral artery disease.

BACKGROUND The incidence of, and risk factors for, acute kidney injury (AKI) after endovascular intervention for peripheral artery disease (PAD) remain unknown. The aim of this study was to assess the proportion of patients who develop AKI and explore the risk factors. METHODS Prospectively collected data on patients undergoing femoropopliteal endovascular intervention for symptomatic PAD across three vascular centres were analysed. The proportion of patients developing AKI (according to the Kidney Disease Improving Global Outcomes definition) within 48 h, and the proportion developing the composite Major Adverse Kidney Events (MAKE) endpoints (death, dialysis, drop in estimated glomerular filtration rate at least 25 per cent) at 30 days (MAKE30) and remains 90 days (MAKE90) were calculated. Multivariable regression analysis was used to assess predictors of AKI, and the association between AKI and death. RESULTS Some 2041 patients were included in the analysis. AKI developed in 239 patients (11.7 per cent), with 47 (2.3 per cent) requiring dialysis within 30 days, and 18 (0.9 per cent) requiring ongoing dialysis. The MAKE30 and MAKE90 composite endpoints were reached in 358 (17.5 per cent) and 449 (22.0 per cent) patients respectively. Risk factors for AKI were age, sex, congestive heart failure, chronic limb-threatening ischaemia, emergency procedure, and pre-existing chronic kidney disease. AKI, dementia, congestive heart failure, and major amputation were risk factors for medium-term mortality. CONCLUSION AKI is a common complication after intervention for PAD and is associated with medium-term mortality.

[1]  N. Dattani,et al.  Acute Kidney Injury (AKI) in Aortic Intervention: Findings From the Midlands Aortic Renal Injury (MARI) Cohort Study. , 2019, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[2]  R. Hinchliffe,et al.  Umbrella review and meta‐analysis of antiplatelet therapy for peripheral artery disease , 2019, The British journal of surgery.

[3]  John V. White,et al.  Global vascular guidelines on the management of chronic limb-threatening ischemia. , 2019, Journal of vascular surgery.

[4]  A. Shepard,et al.  Contrast‐induced nephropathy after peripheral vascular intervention: Long‐term renal outcome and risk factors for progressive renal dysfunction , 2019, Journal of vascular surgery.

[5]  A. Go,et al.  Risk Factors for Recurrent Acute Kidney Injury in a Large Population-Based Cohort. , 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  S. Spiliopoulos,et al.  Risk of Death Following Application of Paclitaxel‐Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials , 2018, Journal of the American Heart Association.

[7]  H. Kurobe,et al.  The ratio of contrast medium volume to estimated glomerular filtration rate as a predictor of contrast-induced nephropathy after endovascular aortic repair. , 2018, The journal of medical investigation : JMI.

[8]  A. Horsch,et al.  Peripheral artery disease , 2018, British Medical Journal.

[9]  M. Sharafuddin,et al.  Current status of carbon dioxide angiography , 2017, Journal of vascular surgery.

[10]  H. Gurm,et al.  Contrast‐induced nephropathy in patients undergoing endovascular peripheral vascular intervention: Incidence, risk factors, and outcomes as observed in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium , 2017, Journal of interventional cardiology.

[11]  A. Levin,et al.  Intermediate and Long-term Outcomes of Survivors of Acute Kidney Injury Episodes: A Large Population-Based Cohort Study , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  K. Calligaro,et al.  Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease. , 2016, Journal of vascular surgery.

[13]  C. Engelbertz,et al.  Long-Term Mortality After Invasive Angiography and Endovascular Revascularization in Patients With PAD Having Chronic Kidney Disease , 2016, Angiology.

[14]  A. Dua,et al.  Epidemiology of Peripheral Arterial Disease and Critical Limb Ischemia. , 2016, Techniques in vascular and interventional radiology.

[15]  A. Krasznai,et al.  Contrast Induced Nephropathy and Long-term Renal Decline After Percutaneous Transluminal Angioplasty for Symptomatic Peripheral Arterial Disease. , 2016, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[16]  J. Kellum,et al.  Acute kidney injury in the era of big data: the 15th Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) , 2016, Canadian journal of kidney health and disease.

[17]  M. Bown,et al.  Long-Term Renal Function after Endovascular Aneurysm Repair. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[18]  P. Sarafidis,et al.  Renal dysfunction after endovascular abdominal aortic aneurysm repair: time to use the correct outcome measures. , 2015, Kidney international.

[19]  M. Bown,et al.  Intervention Associated Acute Kidney Injury and Long-Term Cardiovascular Outcomes , 2015, American Journal of Nephrology.

[20]  Eric E. Smith,et al.  2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). , 2015, Circulation.

[21]  U. Coşkun,et al.  Long-Term Follow-Up of Patients at High Risk for Nephropathy After Contrast Exposure , 2015, Angiology.

[22]  T. Franiel,et al.  Contrast-induced nephropathy in patients with chronic kidney disease and peripheral arterial disease , 2015, Acta radiologica open.

[23]  P. Hayes,et al.  Contrast Medium-Induced Acute Kidney Injury , 2015, Cardiorenal Medicine.

[24]  R. Zietse,et al.  Long-Term Sequelae of Severe Acute Kidney Injury in the Critically Ill Patient without Comorbidity: A Retrospective Cohort Study , 2015, PloS one.

[25]  Anuragini Gupta,et al.  The effect of acute kidney injury after revascularization on the development of chronic kidney disease and mortality in patients with chronic limb ischemia. , 2015, Journal of vascular surgery.

[26]  A. Shaw,et al.  Clinical Trial Endpoints in Acute Kidney Injury , 2014, Nephron Clinical Practice.

[27]  G. Stone,et al.  Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy. , 2014, European heart journal.

[28]  J. B. Layton,et al.  Post-operative acute kidney injury and five-year risk of death, myocardial infarction, and stroke among elective cardiac surgical patients: a cohort study , 2013, Critical Care.

[29]  K. Chien,et al.  Risk of developing severe sepsis after acute kidney injury: a population-based cohort study , 2013, Critical Care.

[30]  U. Sadat.  Radiographic Contrast-Media-Induced Acute Kidney Injury: Pathophysiology and Prophylactic Strategies , 2013, ISRN radiology.

[31]  Mark E. Thomas,et al.  Acute kidney injury: summary of NICE guidance , 2013, BMJ.

[32]  C. Laing,et al.  Contrast-induced acute kidney injury following PCI. , 2013, European journal of clinical investigation.

[33]  P. Li,et al.  Acute kidney injury: global health alert. , 2013, Kidney international.

[34]  P. Li,et al.  Acute kidney injury: global health alert , 2013, Internal medicine journal.

[35]  A. Khwaja.  KDIGO Clinical Practice Guidelines for Acute Kidney Injury , 2012, Nephron Clinical Practice.

[36]  M. Woodward,et al.  Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. , 2012, JAMA.

[37]  H. Gurm,et al.  The changing definition of contrast-induced nephropathy and its clinical implications: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). , 2012, American heart journal.

[38]  Glenn M. Chertow,et al.  Acute Kidney Injury and Mortality in Hospitalized Patients , 2012, American Journal of Nephrology.

[39]  H. Gurm,et al.  Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. , 2011, Journal of the American College of Cardiology.

[40]  S. Ogawa,et al.  Prognostic significance of acute kidney injury after reperfused ST-elevation myocardial infarction: synergistic acceleration of renal dysfunction and left ventricular remodeling. , 2010, Journal of cardiac failure.

[41]  P. Aspelin,et al.  Contrast medium dose-to-gfr ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention , 2008, Acta radiologica.

[42]  M. Yano,et al.  Effect of a contrast agent on long-term renal function and the efficacy of prophylactic hemodiafiltration. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[43]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Epidemiology.

[44]  S. van Buuren.  Multiple imputation of discrete and continuous data by fully conditional specification , 2007, Statistical methods in medical research.

[45]  C. Becker,et al.  Contrast-Induced Nephropathy (CIN) Consensus Working Panel: executive summary. , 2006, Reviews in cardiovascular medicine.

[46]  P. Aspelin,et al.  Contrast-Induced Nephropathy: A Clinical and Evidence-Based Approach , 2006, Circulation.

[47]  Deepak L. Bhatt,et al.  Renal failure after percutaneous coronary intervention is associated with high mortality , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[48]  W. O’Neill,et al.  Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. , 1997, The American journal of medicine.

[49]  S. Bagshaw,et al.  Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: A systematic review and meta-analysis , 2004, BMC medicine.